Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Neuer Gesetzesentwurf!: Kommt nach der Cannabis-Neuregulierung nun eine komplette Legalisierung in USA?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
17 Leser
Artikel bewerten:
(0)

Siemens: Ask the Ultimate Power in Imaging

CHICAGO, Nov. 30 /PRNewswire-FirstCall/ -- At the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, November 30 to December 5, Siemens Healthcare (http://www.siemens.com/healthcare) will demonstrate its latest diagnostic imaging innovations in computed tomography, mammography, magnetic resonance, molecular imaging, ultrasound, and much more at the Siemens booth (Booth #922, East Building/Lakeside Center, Hall D).

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

"There is huge potential to increase the quality and efficiency of healthcare through technological innovation and workflow improvements," said Hermann Requardt, CEO, Siemens Healthcare Sector. "Since 1847 Siemens is renowned for its unrivaled strength in research and development, resulting in the leadership position we hold today. As the world's leading integrated technology company, Siemens brings unparalleled innovations to the medical industry."

Taking center stage at the booth, Siemens' Innovations@RSNA launch area will feature a theater where attendees, through interviews with Siemens' experts, can learn more about the latest technologies and how they are shaping the industry. Interviews are scheduled to take place every half hour while the exhibit hall is opened.

"Siemens' technology is designed to help our customers become successful and achieve their goals," said Dr. Bernd Montag, CEO, Imaging & IT Division, Siemens Healthcare Sector. "By dovetailing our technological expertise and engineering excellence with our deep clinical insights and a fundamental understanding of the business needs of healthcare providers, Siemens continues to deliver groundbreaking innovations. Healthcare providers around the world trust Siemens and our solutions, and have helped us achieve a market-leading position in diagnostic imaging."

The Innovations@RSNA launch area will showcase the following technologies: Computed Tomography

Siemens introduces the SOMATOM(R) Definition Flash, a new dual-source CT that requires only a fraction of the radiation dose that systems previously required to scan even the tiniest anatomical details faster than ever before. The fastest scanning speed in CT (i.e., 43 cm/s) and a temporal resolution of 75 ms, enable complete scans of the entire chest region in just 0.6 seconds. Also, the SOMATOM Definition AS platform introduces a further expansion with its new 20-slice configuration, a large 31-inch (78 cm) gantry bore, optional 660 pounds (300 kg) patient weight capacity and high-scan speed, designed perfectly for high-patient throughput.

Magnetic Resonance

Siemens' latest innovation in MRI, the MAGNETOM(R) Espree - Pink, is a dedicated MR breast scanner which combines the Open Bore design of the MAGNETOM Espree with the Sentinelle Vanguard for Siemens, a breast coil solution that offers exceptional breast imaging and biopsy access. Enabling feet-first and head-first positioning and excellent access to perform biopsies, the system has unparalleled openness with a 70 cm Open Bore and the shortest system on the market (125 cm) for increased comfort. This MR system provides a comprehensive portfolio of routine and advanced applications for breast care, including syngo(R) VIEWS for routine imaging, syngo GRACE for spectroscopy, and syngo BLADE for motion-free imaging results.

Mammography

One of Siemens latest technologies now under development and highlighted in the Innovations@RSNA area is its full-field mammography, breast tomosynthesis(1), a 3D imaging technology that acquires 2D projection images of a compressed breast at multiple angles during a sweep of the X-ray tube. Poised to enhance mammography, the new technology will take the two-dimensional images and reconstruct them to reveal depth - the third dimension of anatomy. Tomosynthesis slices have the potential to show tumors that remain invisible in individual images.

Molecular Imaging

Continuing its leadership in molecular imaging innovation, Siemens showcases Biograph(TM) mCT, the only integrated imaging device to offer routine, whole-body PET scanning in just five minutes, and enables both molecular imaging and radiology to take advantage of its large bore capacity, ultra high-definition technology, combining HD-PET and time-of-flight (TOF), and advanced CT capabilities with up to 128 slices, a first in integrated imaging. Biograph mCT with ultra HD-PET technology is the world's only PET system that offers 2 mm uniform resolution throughout the field of view (FOV), coupled with enhanced contrast with reduced noise, compared to standard PET acquisitions because of the addition of TOF technology. Biograph mCT adapts to virtually all patient types and clinical needs.

Ultrasound

Siemens will also demonstrate the capabilities of the ACUSON S2000 (TM) Automated Breast Volume Scanner (ABVS)(2), the world's first multi-use, automated volume breast ultrasound system. The ACUSON S2000 ABVS system automatically and quickly acquires full-field sonographic volumes for comprehensive review and diagnosis of the breast streamlining workflow and reducing operator dependence and variability. The system also features the intuitive, anatomical coronal plane not available using conventional ultrasound. This view provides a more understandable representation of the global anatomy and architecture of the breast. Semi-automated reporting and comprehensive BI-RADS(R) reporting capabilities further enhance the clinical workflow.

Other innovations highlighted at the Siemens booth at RSNA 2008 include: Angiography, Fluoroscopy & X-ray

New to the Artis zee(R) family is syngo iFlow(3), which, for the first time, shows dynamic information using color in a single image for assessment, enhancing neurological post-therapeutic interventions for rapid evaluation of remaining abnormalities by comparing pre- and post- imaging sequences. Siemens will also highlight the recently FDA-cleared Ysio(TM), a digital radiography system that combines integrated and wireless mobile detector technology into one flexible solution.

Siemens will also introduce three new components to the AXIOM Luminos dRF, a fully-digital 2-in-1 solution with dynamic flat detector for remote controlled fluoroscopy and digital radiography that helps future-proof customers' investment. The new functionality, represented in product simulations, includes the first-to-market wireless detector, a ceiling-mounted X-ray tube, and new wall stand.

Image & Knowledge Management

Siemens will highlight workflow enhancements and demonstrate role-based portals, innovative applications and intelligent information systems. syngo Portal Executive(4), for example, is designed to support proactive management of issues relevant to executives and managers. With syngo Portal Transcriptionist(5), Siemens helps transcriptionists achieve greater efficiency and accuracy when transcribing and correcting reports. Many new enhancements were made to syngo Portal Radiologist, as well as syngo Portal Referring Physician(5). With syngo Suite Essential(6), Siemens offers a comprehensive and cost-effective IT package for Diagnostic Imaging Centers, consisting of preconfigured software, hardware, and services.

(1) Caution: Investigational Device. Limited by U.S. Federal Law to investigational use. The information about Digital Breast Tomosynthesis is preliminary. This product is under development and not commercially available in the U.S., and its future availability cannot be ensured.

(2)This product is pending 510(k) review and is not yet commercially available in the U.S.

(3)The information about this product is being provided for planning purposes. The product requires 510(k) review and is not yet commercially available in the U.S.

(4)This information about this product is preliminary. The product is still under development and not commercially available in the U.S., and its future availability cannot be ensured.

(5)Commercially not available in the U.S. (6)Available for sale in the U.S. only.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first integrated healthcare company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care - from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens Healthcare is the global market leader in innovative hearing instruments. The company employs around 49,000 people worldwide and operates in 130 countries. In the fiscal year 2008 (Sept. 30), Siemens Healthcare reported sales of euro 11.2 billion, orders of euro 11.8 billion, and Sector profit of euro 1.2 billion. Further information can be found by visiting http://www.siemens.com/healthcare.

Photo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO
http://photoarchive.ap.org/
photodesk@prnewswire.com
Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2008 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.